Expression of ERK1/2 protein in lung tissues of newborn rats with hyperoxia-induced chronic lung disease

HU Yu; LIU Xue-Yan; FU Jian-Hua; XUE Xin-Dong

PDF(1493 KB)

Chinese Journal of Contemporary Pediatrics ›› 2011, Vol. 13 ›› Issue (7) : 581-585.

EXPERIMENTAL RESEARCH

Expression of ERK1/2 protein in lung tissues of newborn rats with hyperoxia-induced chronic lung disease

HU Yu, LIU Xue-Yan, FU Jian-Hua, XUE Xin-Dong

Author information +

History +

Abstract

OBJECTIVE: To study the expression of extracellular signal regulated protein kinase (ERK) 1/2 in lung tissues of newborn rats with chronic lung disease (CLD) caused by hyperoxia. METHODS: Forty-eight full-term newborn rats were randomly divided into two groups: hyperoxia and control. The two groups were exposed to a hyperoxic gas mixture (0.90 O2) for an induction of CLD and room air within 12 hrs after birth, respectively. The levels of ERK1/2 protein and mRNA in lung tissues were measured using immunohistochemistry, Western blot and real-time PCR methods on postnatal days 3, 7 and 14. The severity of pulmonary fibrosis was evaluated. RESULTS: The expression of p-ERK protein in lung tissues in the hyperoxia group was significantly higher than that in the control group on postnatal days 7 and 14 (P<0.01). There were no significant differences in the levels of total ERK1/2 protein and ERK1/2 mRNA. CONCLUSIONS: The activation of phosphorated ERK1/2 may lead to lung fibrosis caused by hyperoxia in newborn rats.

Key words

Hyperoxia / Chronic lung disease / Extracellular signal regulated protein kinase / Newborn rats

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

HU Yu, LIU Xue-Yan, FU Jian-Hua, XUE Xin-Dong. Expression of ERK1/2 protein in lung tissues of newborn rats with hyperoxia-induced chronic lung disease[J]. Chinese Journal of Contemporary Pediatrics. 2011, 13(7): 581-585

References

［1］Hayes D Jr, Feola DJ, Murphy BS, Shook LA, Ballard HO. Pathogenesis of bronchopulmonary dysplasia［J］. Respiration, 2010, 79(5):425-436.

［2］Coalson JJ. Pathology of bronchopulmonary dysplasia［J］. Semin Perinatol, 2006, 30(4):179-184.

［3］Kim EK, Choi EJ. Pathological roles of MAPK signaling pathways in human diseases［J］. Biochim Biophys Acta, 2010, 1802(4):396-405.

［4］Jeon GW, Sung DK, Jung YJ, Koo SH, Choi SH, Chang YS, et al. Granulocyte colony stimulating factor attenuates hyperoxia-induced lung injury by down-modulating inflammatory responses in neonatal rats［J］. Yonsei Med J, 2011, 52(1):65-73.

［5］Ashcroft T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale［J］. J Clin Pathol, 1988, 41(4):467-470.

［6］Li LF, Liao SK, Huang CC, Hung MJ, Quinn DA. Serine/threonine kinase-protein kinase B and extracellar signal-regulated kinase regulate ventilatorinduced pulmonary fibrosis after bleomycin-induced acute lung injury: a prospective, controlled animal experiment［J］. Crit Care, 2008, 12(4):R103.

［7］Ko JC, Wang YT, Yang JL. Dual and opposing roles of ERK in regulating G(1) and S-G(2)/M delays in A549 cells caused by hyperoxia［J］. Exp Cell Res, 2004, 297(2):472-483.

［8］Davies PL, Spiller OB, Beeton ML, Maxwell NC, Remold-O'Donnell E, Kotecha S. Relationship of proteinases and proteinase inhibitors with microbial presence in chronic lung disease of prematurity［J］. Thorax, 2010, 65(3):246-251.

［9］Dasgupta C, Sakurai R, Wang Y, Guo P, Ambalavanan N, Torday JS, et al. Hyperoxia-induced neonatal rat lung injury involves activation of TGF-beta and Wnt signaling and is protected by rosiglitazone［J］. Am J Physiol Lung Cell Mol Physiol, 2009, 296(6):L1031-L1041.

［10］Maeda-Yamamoto M, Suzuki N, Sawai Y, Miyase T, Sano M, Hashimoto-Ohta A, et al. Association of suppression of extracellular signal-regulated kinase phosphorylation by epigallocatechin gallate with the reduction of matrix metalloproteinase activities in human fibrosarcoma HT1080 cells［J］. J Agric Food Chem, 2003, 51(7):1858-1863.

［11］Asano K, Shikama Y, Shoji N, Hirano K, Suzaki H, Nakajima H. Tiotropium bromide inhibits TGF-β-induced MMP production from lung fibroblasts by interfering with Smad and MAPK pathways in vitro［J］. Int J Chron Obstruct Pulmon Dis, 2010, 5:277-286.

［12］Jiang HD, Guan HS. MS80, a novel sulfated oligosaccharide, inhibites pulmonary fibrosis by targeting TGF-beta1 both in vitro and in vivo［J］. Acta Pharmacol Sin, 2009, 30(7):973-979.

［13］Ranganathan AC, Nelson KK, Rodriguez AM, Kim KH, Tower GB, Rutter JL, et al. Manganese superoxide dismutase signals matrix metalloproteinase expression via H2O2dependent ERK1/2 activation［J］. J Biol Chem, 2001, 276(17):14264-14270.

［14］Fang LP, Lin Q, Tang CS, Liu XM. Hydrogen sulfide suppresses migration, proliferation and myofibroblast transdifferentiation of human lung fibroblasts［J］. Pulm Pharmacol Ther, 2009, 22(6):554-561.

［15］Lin Q, Fang LP, Zhou WW, Liu XM. Rosiglitazone inhibits migration, proliferation, and phenotypic differentiation in cultured human lung fibroblasts［J］. Exp Lung Res, 2010, 36(2):120-128.